Galal Mahmoud Abdelghani

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
A stable controlled release resinate-complex for the highly bitter taste famotidine (FAM) was developed to allow once-daily administration and improve patient compliance especially in pediatric and geriatric medicine. The drug-resinate complexes were prepared in different drug to resin (Amberlite IRP-69) ratios by weight (1:1, 1:2, 1:3, 1:4, 1:5 and 1:6).(More)
  • 1